Astrana Health, Inc. (ASTH) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-15

Key Insights

Chandan Basho, the COO and CFO of Astrana Health, Inc., has disposed of 3,870 shares of common stock through a withholding transaction to cover tax obligations on vested restricted stock.
Basho continues to hold a significant number of shares, including 167,765 shares of common stock and unvested restricted stock units that will vest over the next year.
The transaction appears to be a routine tax withholding event and does not necessarily indicate a negative view of the company's prospects.

Want the newest filings?

This analysis covers the filing from 2026-04-15. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-08

Insider Brandon Sim, the CEO and President, acquired a substantial amount of 201,056 restricted stock units in Astrana Health, Inc. (ASTH), indicating his confidence in the company's future.
Sim also holds significant indirect ownership in the company through the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust, suggesting long-term alignment with shareholders.
The vesting schedule for the restricted stock units, with eight semi-annual installments starting in October 2026, suggests a long-term commitment by the CEO to the company's success.

Filed: 2026-04-08

The reporting person, Kenneth T. Sim, is the Executive Chairman of Astrana Health, Inc. and owns a significant amount of the company's stock, both directly and indirectly through various trusts and entities.
Sim has recently been granted 100,000 restricted stock units (RSUs) that will vest in eight semi-annual installments, indicating the company is incentivizing him with equity-based compensation.
Sim also has additional unvested restricted stock grants that will vest over the next two years, further aligning his interests with those of the company and shareholders.

Filed: 2026-04-08

Insider Thomas Lam acquired 41,667 restricted stock units, vesting over 4 years, demonstrating his long-term commitment to Astrana Health.
Lam also holds a substantial indirect ownership stake of over 7.2 million shares through his roles at Allied Physicians and a family trust, aligning his interests with other shareholders.
The restricted stock grants and insider ownership suggest a positive outlook from management on Astrana Health's future growth and performance.

Filed: 2026-03-30

The reporting person, Glenn Sobotka, is the Chief Accounting Officer of Astrana Health, Inc. and is reporting the disposition of 662 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.
Sobotka continues to beneficially own 14,039 shares of Astrana Health's common stock, including 4,824 shares of restricted stock that will vest over the next three years and 8,269 shares of performance-based restricted stock.
The transaction appears to be a routine tax withholding event and does not indicate any significant change in Sobotka's ownership position or his confidence in the company.

Filed: 2026-03-09

Insider Chandan Basho, the COO and CFO of Astrana Health, Inc. (ASTH), sold 1,240 shares of common stock on March 5, 2026, likely to cover tax withholding obligations on vesting of restricted stock units.
Basho still holds a significant number of unvested restricted stock and restricted stock units, totaling 57,149 shares, which will continue to vest over the next two years, aligning his interests with those of shareholders.
The insider transaction appears to be routine in nature and likely not indicative of a broader negative sentiment on the company or its prospects.

Filed: 2026-03-09

Insider Dinesh M. Kumar, the Chief Medical Officer, disposed of 1,697 shares of Astrana Health, Inc. (ASTH) common stock on March 5, 2026, likely to cover tax withholding obligations associated with vesting restricted stock units.
Kumar continues to hold a significant ownership stake in Astrana Health, with 200,335 shares beneficially owned, including unvested restricted stock and restricted stock units.
The filing indicates that Kumar's equity compensation is tied to both time-based vesting and achievement of certain performance goals, which could signal the company's focus on aligning executive incentives with long-term shareholder value creation.

Filed: 2026-03-09

Insider Thomas S. Lam, a director of Astrana Health, Inc., sold 9,266 shares of common stock on March 5, 2026, likely to cover tax withholding obligations associated with vesting of restricted stock.
Lam still holds a significant beneficial ownership stake in the company, with 423,990 direct shares and additional 7,266,508 shares held indirectly through two entities.
The transaction appears to be a routine stock sale by an insider to cover tax obligations, rather than a significant change in Lam's overall ownership position.

Filed: 2026-01-27

Dinesh M. Kumar, the Chief Medical Officer of Astrana Health, Inc., recently disposed of 10,759 shares of the company's common stock to cover tax withholding obligations associated with vesting restricted stock.
Kumar currently holds 202,032 shares of Astrana Health, including 28,378 shares of restricted stock that will vest in 2027, as well as grants of 8,158 and 3,264 shares subject to performance goals, and 67,238 and 23,364 restricted stock units.
The insider transaction appears to be a routine cash-for-share exchange for tax purposes and does not necessarily indicate any significant change in Kumar's long-term outlook on the company.

Filed: 2026-01-15

The reporting person, David Schmidt, has exercised 20,000 stock options at a price of $5.79 and disposed of 4,269 shares at $27.12, indicating a mix of insider buying and selling activity.
Schmidt continues to beneficially own 31,494 shares of Astrana Health, Inc. (ASTH), including 6,449 shares of restricted stock that will vest in the near future.
The timing of the transactions, occurring on January 13, 2026, suggests the reporting person may have knowledge of upcoming company events or performance.

Other reports for Astrana Health, Inc.

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.